Cambridge Investment Research Advisors Inc. lowered its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 7.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,052 shares of the biotechnology company's stock after selling 813 shares during the quarter. Cambridge Investment Research Advisors Inc.'s holdings in Axon Enterprise were worth $5,287,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Pinion Investment Advisors LLC boosted its holdings in Axon Enterprise by 3.0% during the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock valued at $341,000 after acquiring an additional 19 shares during the period. Kentucky Retirement Systems lifted its position in Axon Enterprise by 0.4% in the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock valued at $2,605,000 after purchasing an additional 19 shares during the last quarter. Beacon Pointe Advisors LLC boosted its stake in shares of Axon Enterprise by 2.6% during the fourth quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company's stock valued at $513,000 after purchasing an additional 22 shares during the period. Fielder Capital Group LLC grew its holdings in shares of Axon Enterprise by 2.2% in the fourth quarter. Fielder Capital Group LLC now owns 1,176 shares of the biotechnology company's stock worth $699,000 after purchasing an additional 25 shares during the last quarter. Finally, Interchange Capital Partners LLC increased its stake in shares of Axon Enterprise by 1.9% in the fourth quarter. Interchange Capital Partners LLC now owns 1,310 shares of the biotechnology company's stock worth $779,000 after buying an additional 25 shares during the period. 79.08% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on AXON. Bank of America increased their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Needham & Company LLC raised their target price on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Finally, Barclays increased their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $699.55.
Get Our Latest Stock Report on AXON
Insider Activity at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Joshua Isner sold 905 shares of the firm's stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total value of $702,632.95. Following the transaction, the president now owns 268,735 shares of the company's stock, valued at $208,643,166.65. The trade was a 0.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock valued at $30,500,428 in the last three months. Company insiders own 4.40% of the company's stock.
Axon Enterprise Stock Up 1.8%
Shares of NASDAQ:AXON traded up $14.65 during trading on Friday, hitting $818.60. The stock had a trading volume of 1,010,596 shares, compared to its average volume of 540,419. The company has a market capitalization of $63.73 billion, a PE ratio of 197.73, a PEG ratio of 94.23 and a beta of 1.29. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The firm's fifty day moving average is $714.97 and its 200 day moving average is $630.47. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $820.83.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the prior year, the company earned $1.15 earnings per share. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. Analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.